Krebs Biochemicals and Industries Limited (KREBSBIO) — Board Meeting | 6 August 2026
The board approved unaudited Q1 FY26 results and a limited auditor review, confirming financials for the quarter ended June 30, 2026, after a meeting from 11:30 am to 1:30 pm.
About Krebs Biochemicals and Industries Limited (KREBSBIO)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when KREBSBIO files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track KREBSBIO — Free💡 Ask AI about this filing
📊 More KREBSBIO filings
- 🟡 Board Meeting — 29 September 2026Krebs Biochemicals & Industries held its 34th AGM on September 29, 2026 via video conference, approv...
- 🟡 Voting Results — 29 September 2026Krebs Biochemicals & Industries Limited announced voting results from its September 29, 2026 AGM, co...
- Announcement — 21 September 2026Krebs Biochemicals & Industries Ltd announced that its trading window will close on September 30, 20...
- 🟡 Board Meeting — 4 September 2026Krebs Biochemicals & Industries Limited announced its 34th Annual General Meeting (AGM) to be held o...
- 🔴 Annual Report — 4 September 2026Krebs Biochemicals & Industries Limited reported a consolidated net loss of ₹1,693.31 Lakhs for FY 2...
🔥 Also filed on 6 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when KREBSBIO files new disclosures
Track KREBSBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track KREBSBIO — FreeFree account · 2 AI queries/day